Haemophilia treatment in the United Kingdom from 1969 to 1974.
A study has been made by the Haemophilia Centre Directors of the United Kingdom and Northern Ireland. From 1969 to 1974 2600 patients with haemophilia A and 388 with haemophilia B attended Haemophilia Centres for treatment. Of these patients, 71 are known to have died in the survey period. A record is presented of the amounts and types of therapeutic materials used each year during this time. The incidenceof jaundice and anti-factor VIII and anti-factor IX antibodies was recorded.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005164:Factor IX / Q000276:immunology / Q000627:therapeutic use*; D005169:Factor VIII / Q000276:immunology / Q000600:supply & distribution / Q000627:therapeutic use*; D006467:Hemophilia A / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D002836:Hemophilia B / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D006525:Hepatitis, Viral, Human / Q000150:complications; D006699:Home Care Services; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007565:Jaundice / Q000150:complications; D008297:Male; D008875:Middle Aged; D006113:United Kingdom
D000906:Antibodies; D005169:Factor VIII; D005164:Factor IX